Current Neuropharmacology
Title:Meet Our Editorial Board Member
Volume: 17 Issue: 4
Author(s): K. Ballanyi
Affiliation:
Export Options
About this article
Cite this article as:
Ballanyi K. , Meet Our Editorial Board Member, Current Neuropharmacology 2019; 17 (4) . https://dx.doi.org/10.2174/1570159X1704190306102222
DOI https://dx.doi.org/10.2174/1570159X1704190306102222 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
26
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Network based Approach to Drug Discovery: A Mini Review
Mini-Reviews in Medicinal Chemistry Nanovesicle Formulation Enhances Anti-inflammatory Property and Safe Use of Piroxicam
Pharmaceutical Nanotechnology Selective Androgen Receptor Modulators Antagonize Apolipoprotein E4-Induced Cognitive Impairments
Letters in Drug Design & Discovery EZH2 RIP-seq Identifies Tissue-specific Long Non-coding RNAs
Current Gene Therapy Interaction Between Genetic Polymorphisms in Renin-Angiotensin System (RAS) and Therapeutic Efficacy of RAS Blockade in IgA Nephropathy
Current Pharmacogenomics Deep Brain Stimulation for Alzheimer’s Disease
Current Alzheimer Research Drugs Behave as Substrates, Inhibitors and Inducers of Human Cytochrome P450 3A4
Current Drug Metabolism Review and Research on Feature Selection Methods from NMR Data in Biological Fluids. Presentation of an Original Ensemble Method Applied to Atherosclerosis Field
Current Drug Metabolism Advances of Molecular Imaging Probes for the Diagnosis of Alzheimer's Disease
Current Alzheimer Research Thrombin Activable Fibrinolysis Inhibitor (TAFI): Molecular Genetics of an Emerging Potential Risk Factor for Thrombotic Disorders
Current Drug Targets - Cardiovascular & Hematological Disorders Gene Expression Studies in Multiple Sclerosis
Current Genomics Preface
Adolescent Psychiatry Impact of Online Teaching on Students’ Education and Health in India during the Pandemic of COVID-19
Coronaviruses Addressing the Health, Developmental and Social Outcomes of Children Exposed to Perinatal and Infectious Risks
Infectious Disorders - Drug Targets Potential for Stem Cells Therapy in Alzheimer’s Disease: Do Neurotrophic Factors Play Critical Role?
Current Alzheimer Research Alternatively Spliced Genes as Biomarkers for Schizophrenia, Bipolar Disorder and Psychosis: A Blood-Based Spliceome-Profiling Exploratory Study (Supplementry Table)
Current Pharmacogenomics and Personalized Medicine The Many Faces of Amyloid β in Alzheimers Disease
Current Molecular Medicine Phosphodiesterase 4 Inhibitors in Inflammatory Bowel Disease: A Comprehensive Review
Current Pharmaceutical Design Cardiovascular Magnetic Resonance Imaging clarifies cardiac pathophysiology in early, asymptomatic diffuse systemic sclerosis
Inflammation & Allergy - Drug Targets (Discontinued) Rho-ROCK Inhibitors for the Treatment of CNS Injury
Recent Patents on CNS Drug Discovery (Discontinued)